October 2026 Lab NCD Edit Update: What Labs Need to Do
Short answer: CMS's October 2026 update to the laboratory national coverage determination edit software changes ICD-10-CM code lists for 11 of the 23 lab NCDs. Old codes were deleted September 30, new codes took effect October 1, and implementation is October 5, 2026. Labs should refresh diagnosis-code crosswalks and claim scrubbers now.
What did CMS change in the October 2026 lab NCD edit update?
On July 2, 2026, CMS issued Transmittal R13849CP, titled "Changes to the Laboratory National Coverage Determination (NCD) Edit Software for October 2026," along with the educational article MM14536 for providers. The change request directs the CMS contractor that maintains the edit module to delete ICD-10-CM codes effective September 30, 2026 and add new codes effective October 1, 2026 across 11 NCDs. Shared System Maintainers then install and distribute the updated module. The implementation date is October 5, 2026.
The eleven affected policies are HIV Testing (Diagnosis) 190.14, Blood Counts 190.15, Partial Thromboplastin Time 190.16, Prothrombin Time 190.17, Serum Iron Studies 190.18, Blood Glucose Testing 190.20A and 190.20B, Thyroid Testing 190.22, Digoxin Therapeutic Drug Assay 190.24, Gamma Glutamyl Transferase 190.32, and Fecal Occult Blood Test 190.34.
How does the laboratory NCD edit module work?
According to the transmittal, nationally uniform software was developed and incorporated into the Medicare shared systems so that laboratory claims subject to one of 23 NCDs are processed uniformly across the country. That arrangement took effect April 1, 2003. The 23 policies sit in the Medicare NCD Manual, Chapter 1, Part 3, sections 190.12 through 190.34, as described in MM14536.
CMS states that the module is updated quarterly as necessary to reflect ministerial coding updates and substantive changes to the NCDs. MM14536 adds that updates are driven by coding analysis and the biannual ICD-10-CM updates. In practice, this means a diagnosis code that passed an edit in September can fail the same edit in October if it was removed from, or never added to, the NCD's covered-code list.
Why does the timing matter for revenue cycle teams?
The edit changes land in the same week as the annual ICD-10-CM update. ACDIS, summarizing the CMS release, reports that the FY2027 code set effective October 1, 2026 includes 190 new codes, 30 deleted codes, and 4 revised codes. Because the edit module deletes codes effective September 30 and adds codes effective October 1, labs should confirm with their billing system vendor how date of service is handled around that boundary.
MM14536 tells billing staff to make sure they know which NCDs have added and deleted ICD-10-CM codes. The specific codes are not printed in the article. CMS points readers to Change Request 14536 and an attached spreadsheet, distributed as a zip file named October-2026 on CMS.gov. That spreadsheet is the authoritative list; anything a vendor or consultant summarizes should be checked against it.
Does this affect genetic testing claims directly?
Not in the sense that matters most to molecular labs. None of the eleven NCDs named in the update is a genetic or molecular test; they cover common chemistry, hematology, coagulation, and screening services. Genetic and molecular tests are generally governed by local coverage determinations, such as the MolDX pharmacogenomics testing LCDs published in the CMS Medicare Coverage Database, rather than by the 23 laboratory NCDs. See our guide to Medicare coverage for genetic testing for how NCDs, LCDs, and MolDX fit together.
The update still matters to genetic testing labs in two ways. First, many labs also run routine panels, such as blood counts, coagulation studies, or thyroid tests, alongside genetic work, and those claims pass through the same edit module. Second, the annual ICD-10-CM changes that arrive in the same week affect diagnosis coding on every claim, including hereditary-condition claims. Our review of FY2027 ICD-10 codes for hereditary cancer covers the genetic side of that update.
What should labs do this week?
Start by pulling the October 2026 spreadsheet from CMS.gov and comparing it with the diagnosis-code tables in your billing system, LIS, and claim scrubber. Focus first on the eleven NCDs above, prioritizing the ones your lab bills most often. Next, ask your system vendor how date of service is handled around the September 30 and October 1 boundary.
Then monitor your first October remittances. A rise in denials for tests that were previously paid, especially with the same diagnosis codes, is the signal that a code was deleted or an expected code was not added. Route those denials to a coding review before filing appeals. For a broader framework on prevention, see genetic testing denials, and for code-level reference, see ICD-10 codes for genetic testing.
Finally, remember that ordering clinicians supply the diagnosis. Share the change with client-facing teams and ordering practices so that requisitions carry specific, current ICD-10-CM codes. For lab workflows that check diagnosis codes and coverage criteria before submission, explore the platform at ScreenMyGene.
Frequently asked questions
When does the October 2026 lab NCD edit update take effect?
CMS lists the effective date as October 1, 2026, with an implementation date of October 5, 2026. Deleted ICD-10-CM codes are removed effective September 30, 2026, and added codes take effect October 1, 2026, according to Change Request 14536.
Which laboratory NCDs had code changes?
Eleven NCDs changed: HIV testing, blood counts, PTT, PT, serum iron studies, both blood glucose testing policies, thyroid testing, digoxin assay, gamma glutamyl transferase, and fecal occult blood test. The remaining twelve of the 23 laboratory NCDs were not part of this update.
Where can I find the exact ICD-10-CM codes added or deleted?
MM14536 does not list the codes. CMS refers readers to Change Request 14536 and an attached spreadsheet, available as a zip file named October-2026 on CMS.gov. Use that file as the source of truth when updating your billing system.
Are genetic tests subject to these 23 NCDs?
None of the eleven changed NCDs addresses genetic testing. Genetic and molecular tests are generally covered through local coverage determinations, including MolDX policies, though labs billing routine tests alongside genetic work still pass through the same edit module for those claims.
How often is the laboratory NCD edit module updated?
CMS says the module is updated quarterly as necessary to reflect ministerial coding updates and substantive NCD changes. Labs should therefore expect another review point each quarter and build a recurring check into their coding and denial-management calendar.
This article is educational and intended for laboratory and revenue cycle professionals. It is not legal, coding, or reimbursement advice, and it does not replace payer or CMS documents. Verify all code lists against current CMS publications before billing.
Sources: CMS MM14536, "Laboratory NCD Edit Software: October 2026 Update"; CMS Transmittal R13849CP (Change Request 14536), July 2, 2026; ACDIS, "ICD-10-CM code set for fiscal year 2027 released"; CMS Medicare Coverage Database, MolDX Pharmacogenomics Testing LCDs.